Merck inks pact with Dr Falk Pharma to discontinue certain development and commercialization rights to MK-8690, an investigational anti-CD30 ligand mAb: Rahway, New Jersey Wednesd ...
Cipla acquires Inzpera Healthsciences in a deal heralding pharma's new era of empathetic innovation: Our Bureau, Chennai Wednesday, November 5, 2025, 13:50 Hrs [IST] Pharmaceutica ...
Ajanta Pharma net profit up by 20%, interim dividend of Rs. 28 per share: Our Bureau, Mumbai Wednesday, November 5, 2025, 13:10 Hrs [IST] Ajanta Pharma, a Rs. 4,600 crore plus pha ...
Metropolis Healthcare revenues jump by 23% in Q2, interim dividend of 200%: Our Bureau, Mumbai Wednesday, November 5, 2025, 13:20 Hrs [IST] Metropolis Healthcare, India’s second ...
Mobisoft Infotech optimizes medical transportation for chronic care patients with an advanced NEMT solution: Our Bureau, Bengaluru Wednesday, November 5, 2025, 13:40 Hrs [IST] Mob ...
US marketing authorization for its Covid-19 vaccine, Nuvaxovid to Sanofi, enabling Sanofi to take full responsibility for commercial and regulatory activities in the US and fulfilling part of its ...
New NIHR Research Professors to tackle urgent health challenges: United Kingdom Wednesday, November 5, 2025, 13:00 Hrs [IST] The NIHR has announced 6 new outstanding leaders to be ...
US FDA grants 510(k) clearance to QuidelOrtho’s VITROS hs Troponin I Assay: San Diego Tuesday, November 4, 2025, 18:00 Hrs ...
Bristol Myers Squibb showcases new long-term and real-world data from cardiovascular portfolio at the AHA scientific sessions 2025: Princeton, New Jersey Wednesday, November 5, 20 ...
Pfizer files federal antitrust claims in second lawsuit against Metsera, its controlling stockholders and Novo Nordisk: New York Wednesday, November 5, 2025, 10:00 Hrs [IST] Pfize ...
Merck, known as MSD outside of the United States and Canada, announced that the company has entered into an agreement to receive funds managed by Blackstone Life Sciences (Blackstone) for the ...